129 related articles for article (PubMed ID: 36513934)
21. Simultaneous visualization and cell-specific confirmation of RNA and protein in the mouse retina.
Stempel AJ; Morgans CW; Stout JT; Appukuttan B
Mol Vis; 2014; 20():1366-73. PubMed ID: 25352743
[TBL] [Abstract][Full Text] [Related]
22. HER2 immunohistochemistry in endometrial and ovarian clear cell carcinoma: discordance between antibodies and with in-situ hybridisation.
Koopman T; van der Vegt B; Dijkstra M; Bart J; Duiker E; Wisman GBA; de Bock GH; Hollema H
Histopathology; 2018 Nov; 73(5):852-863. PubMed ID: 29989198
[TBL] [Abstract][Full Text] [Related]
23. Human epidermal growth factor receptor 2 testing in primary breast cancer in the era of standardized testing: a Canadian prospective study.
Hanna WM; Barnes PJ; Chang MC; Gilks CB; Magliocco AM; Rees H; Quenneville L; Robertson SJ; SenGupta SK; Nofech-Mozes S
J Clin Oncol; 2014 Dec; 32(35):3967-73. PubMed ID: 25385731
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor receptor status in hyperparathyroidism: immunocytochemical and In situ hybridization study.
Sadler GP; Morgan JM; Jasani B; Douglas-Jones A; Wheeler MH
World J Surg; 1996 Sep; 20(7):736-42; discussion 742-3. PubMed ID: 8678944
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic algorithm for detection of targetable driver mutations in lung adenocarcinomas: Comprehensive analyses of 205 cases with immunohistochemistry, real-time PCR and fluorescence in situ hybridization methods.
Kao HL; Yeh YC; Lin CH; Hsu WF; Hsieh WY; Ho HL; Chou TY
Lung Cancer; 2016 Nov; 101():40-47. PubMed ID: 27794407
[TBL] [Abstract][Full Text] [Related]
26. Novel
Hirai N; Sasaki T; Okumura S; Sado M; Akiyama N; Kitada M; Takei H; Ohsaki Y
Transl Lung Cancer Res; 2020 Apr; 9(2):257-268. PubMed ID: 32420065
[TBL] [Abstract][Full Text] [Related]
27. In situ detection of Aspergillus 18S ribosomal RNA in invasive pulmonary aspergillosis.
Kobayashi M; Sonobe H; Ikezoe T; Hakoda E; Ohtsuki Y; Taguchi H
Intern Med; 1999 Jul; 38(7):563-9. PubMed ID: 10435362
[TBL] [Abstract][Full Text] [Related]
28. Clinical characteristics and outcomes of patients with primary lung adenocarcinoma harboring ALK rearrangements detected by FISH, IHC, and RT-PCR.
Wang J; Cai Y; Dong Y; Nong J; Zhou L; Liu G; Su D; Li X; Wu S; Chen X; Qin N; Zeng X; Zhang H; Zhang Z; Zhang S
PLoS One; 2014; 9(7):e101551. PubMed ID: 24992725
[TBL] [Abstract][Full Text] [Related]
29. Automated in situ hybridization and immunohistochemistry for cytomegalovirus detection in paraffin-embedded tissue sections.
Lu DY; Qian J; Easley KA; Waldrop SM; Cohen C
Appl Immunohistochem Mol Morphol; 2009 Mar; 17(2):158-64. PubMed ID: 19521278
[TBL] [Abstract][Full Text] [Related]
30. EGFR mutation status in Tunisian non-small-cell lung cancer patients evaluated by mutation-specific immunohistochemistry.
Mraihi Z; Ben Amar J; Bouacha H; Rammeh S; Hila L
BMC Pulm Med; 2018 Aug; 18(1):132. PubMed ID: 30092812
[TBL] [Abstract][Full Text] [Related]
31. Intratumoral heterogeneity of copy number variation in lung cancer harboring L858R via immunohistochemical heterogeneous staining.
Hashimoto T; Osoegawa A; Takumi Y; Abe M; Kobayashi R; Miyawaki M; Takeuchi H; Okamoto T; Sugio K
Lung Cancer; 2018 Oct; 124():241-247. PubMed ID: 30268468
[TBL] [Abstract][Full Text] [Related]
32. Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction.
Wu SG; Chang YL; Lin JW; Wu CT; Chen HY; Tsai MF; Lee YC; Yu CJ; Shih JY
PLoS One; 2011; 6(8):e23303. PubMed ID: 21858063
[TBL] [Abstract][Full Text] [Related]
33. Anaplastic lymphoma kinase 5A4 immunohistochemistry as a diagnostic assay in lung cancer: A Canadian reference testing center's results in population-based reflex testing.
Fiset PO; Labbé C; Young K; Craddock KJ; Smith AC; Tanguay J; Pintilie M; Wang R; Torlakovic E; Cheung C; da Cunha Santos G; Ko HM; Boerner SL; Hwang DM; Leighl NB; Tsao MS
Cancer; 2019 Nov; 125(22):4043-4051. PubMed ID: 31390053
[TBL] [Abstract][Full Text] [Related]
34. Identification of EGFR Mutations by Immunohistochemistry with EGFR Mutation-Specific Antibodies in Biopsy and Resection Specimens from Pulmonary Adenocarcinoma.
Kim CH; Kim SH; Park SY; Yoo J; Kim SK; Kim HK
Cancer Res Treat; 2015 Oct; 47(4):653-60. PubMed ID: 25687872
[TBL] [Abstract][Full Text] [Related]
35. Rapid automated combined in situ hybridization and immunohistochemistry for sensitive detection of cytomegalovirus in paraffin-embedded tissue biopsies.
Rimsza LM; Vela EE; Frutiger YM; Rangel CS; Solano M; Richter LC; Grogan TM; Bellamy WT
Am J Clin Pathol; 1996 Oct; 106(4):544-8. PubMed ID: 8853045
[TBL] [Abstract][Full Text] [Related]
36. Detection of c-erbB-2 mRNAs using dig-labelled oligonucleotide probe with in situ hybridisation in human breast carcinoma: comparison with immunohistochemical results.
Oztürk M; Bolkent S; Yilmazer S; Kaner G; Unal H
Anal Cell Pathol; 1998; 16(4):201-9. PubMed ID: 9762367
[TBL] [Abstract][Full Text] [Related]
37. RNA In Situ Hybridization for Epstein-Barr Virus and Cytomegalovirus: Comparison With In Situ Hybridization and Immunohistochemistry.
Roe CJ; Siddiqui MT; Lawson D; Cohen C
Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):155-159. PubMed ID: 28800011
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemistry with a novel mutation-specific monoclonal antibody as a screening tool for the EGFR L858R mutational status in primary lung adenocarcinoma.
Ping W; Xia C; Fu S; Cai Y; Deng Y; Sun W; Dong C; Fu X
Tumour Biol; 2015 Feb; 36(2):693-700. PubMed ID: 25286755
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma.
Jung YY; Yoo JH; Park ES; Kim MK; Lee TJ; Cho BY; Chung YJ; Kang KH; Ahn HY; Kim HS
Pathol Res Pract; 2015 Feb; 211(2):162-70. PubMed ID: 25468810
[TBL] [Abstract][Full Text] [Related]
40. Novel epidermal growth factor receptor mutation-specific antibodies for non-small cell lung cancer: immunohistochemistry as a possible screening method for epidermal growth factor receptor mutations.
Kato Y; Peled N; Wynes MW; Yoshida K; Pardo M; Mascaux C; Ohira T; Tsuboi M; Matsubayashi J; Nagao T; Ikeda N; Hirsch FR
J Thorac Oncol; 2010 Oct; 5(10):1551-8. PubMed ID: 20697298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
